Medesis Pharma (France) Market Value
| ALMDP Stock | EUR 0.42 0.01 2.33% |
| Symbol | Medesis |
Medesis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medesis Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medesis Pharma.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Medesis Pharma on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Medesis Pharma SA or generate 0.0% return on investment in Medesis Pharma over 30 days. Medesis Pharma is related to or competes with Biophytis, Gensight Biologics, OSE Pharma, and Abivax SA. Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administ... More
Medesis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medesis Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medesis Pharma SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 75.63 | |||
| Value At Risk | (16.19) | |||
| Potential Upside | 16.22 |
Medesis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medesis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medesis Pharma's standard deviation. In reality, there are many statistical measures that can use Medesis Pharma historical prices to predict the future Medesis Pharma's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (2.02) | |||
| Treynor Ratio | (0.36) |
Medesis Pharma SA Backtested Returns
Medesis Pharma SA has Sharpe Ratio of -0.2, which conveys that the firm had a -0.2% return per unit of risk over the last 3 months. Medesis Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medesis Pharma's Mean Deviation of 6.73, risk adjusted performance of (0.01), and Standard Deviation of 10.93 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.84, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medesis Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medesis Pharma is expected to be smaller as well. At this point, Medesis Pharma SA has a negative expected return of -1.6%. Please make sure to verify Medesis Pharma's total risk alpha and the relationship between the skewness and relative strength index , to decide if Medesis Pharma SA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.10 |
Insignificant predictability
Medesis Pharma SA has insignificant predictability. Overlapping area represents the amount of predictability between Medesis Pharma time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medesis Pharma SA price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Medesis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Medesis Pharma SA lagged returns against current returns
Autocorrelation, which is Medesis Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medesis Pharma's stock expected returns. We can calculate the autocorrelation of Medesis Pharma returns to help us make a trade decision. For example, suppose you find that Medesis Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medesis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medesis Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medesis Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medesis Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Medesis Pharma Lagged Returns
When evaluating Medesis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medesis Pharma stock have on its future price. Medesis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medesis Pharma autocorrelation shows the relationship between Medesis Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Medesis Pharma SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.